TNF-α upregulates sclerostin expression in obese mice fed a high-fat diet

Journal of Cellular Physiology

Volumn 229, Issue 5, 2014, Pages 640-650

  Baek, Kyunghwa ^a,b   Hwang, Hyo Rin ^a   Park, Hyun Jung ^a   Kwon, Arang ^a   Qadir, Abdul S ^a   Ko, Seong Hee ^b   Woo, Kyung Mi ^a   Ryoo, Hyun Mo ^a   Kim, Gwan Shik ^a   Baek, Jeong Hwa ^a  

^a Seoul National University   (South Korea)

^b Gangneung Wonju National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MINERAL; SCLEROSTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BODY FAT; BODY WEIGHT; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DENSITY; IMMUNOPRECIPITATION; INFLAMMATORY DISEASE; LIPID DIET; LUCIFERASE ASSAY; MALE; MASS; MOUSE; NONHUMAN; OBESITY; OSSIFICATION; OSTEOCYTE; OSTEOLYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BODY COMPOSITION; BONE DENSITY; CELL LINE; DIETARY FATS; GLYCOPROTEINS; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; OBESITY; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84892665506     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24487     Document Type: Article

References (41)

1. Bacchetta J, Boutroy S, Guebre-Egziabher F, Juillard L, Drai J, Pelletier S, Richard M, Charrie A, Carlier MC, Chapurlat R, Laville M, Fouque D. 2009. The relationship between adipokines, osteocalcin and bone quality in chronic kidney disease. Nephrol Dial Transplant 24:3120-3125.
2. Baek K, Bloomfield SA. 2009. Beta-adrenergic blockade and leptin replacement effectively mitigate disuse bone loss. J Bone Miner Res 24:792-799.
3. Baek K, Bloomfield SA. 2012. Blocking beta-adrenergic signaling attenuates reductions in circulating leptin, cancellous bone mass, and marrow adiposity seen with dietary energy restriction. J Appl Physiol 113:1792-1801.
4. Balage M, Sinaud S, Prod'homme M, Dardevet D, Vary TC, Kimball SR, Jefferson LS, Grizard J. 2001. Amino acids and insulin are both required to regulate assembly of the eIF4E. eIF4G complex in rat skeletal muscle. Am J Physiol Endocrinol Metab 281:E565-E574.
5. Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R, Defronzo RA, Cusi K. 2005. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54:1640-1648.
6. Bozic B, Loncar G, Prodanovic N, Radojicic Z, Cvorovic V, Dimkovic S, Popovic-Brkic V. 2010. Relationship between high circulating adiponectin with bone mineral density and bone metabolism in elderly males with chronic heart failure. J Card Fail 16:301-307.
7. Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, Zhao L, Sabo PJ, Fu Y, Alisch RS, Gillett L, Colbert T, Tacconi P, Galas D, Hamersma H, Beighton P, Mulligan J., 2001. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68:577-589.
8. Cao JJ, Gregoire BR, Gao H., 2009. High-fat diet decreases cancellous bone mass but has no effect on cortical bone mass in the tibia in mice. Bone 44:1097-1104.
9. Chan G, Chen CT. 2009. Musculoskeletal effects of obesity. Curr Opin Pediatr 21:65-70.
10. Chen JR, Lazarenko OP, Wu X, Tong Y, Blackburn ML, Shankar K, Badger TM, Ronis MJ. 2010. Obesity reduces bone density associated with activation of PPARgamma and suppression of Wnt/beta-catenin in rapidly growing male rats. PLoS ONE 5:e13704.
11. Cho YD, Yoon WJ, Woo KM, Baek JH, Lee G, Cho JY, Ryoo HM. 2009. Molecular regulation of matrix extracellular phosphoglycoprotein expression by bone morphogenetic protein-2. J Biol Chem 284:25230-25240.
12. Coe LM, Irwin R, Lippner D, McCabe LR. 2011. The bone marrow microenvironment contributes to type I diabetes induced osteoblast death. J Cell Physiol 226:477-483.
13. Cope AP, Liblau RS, Yang XD, Congia M, Laudanna C, Schreiber RD, Probert L, Kollias G, McDevitt HO. 1997. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med 185:1573-1584.
14. Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM. 2013. Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2-17.
15. Eldar-Finkelman H, Schreyer SA, Shinohara MM, LeBoeuf RC, Krebs EG. 1999. Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes 48:1662-1666.
16. Forbes GB, Welle SL., 1983. Lean body mass in obesity. Int J Obes 7:99-107.
17. Graham LS, Tintut Y, Parhami F, Kitchen CM, Ivanov Y, Tetradis S, Effros RB. 2010. Bone density and hyperlipidemia: The T-lymphocyte connection. J Bone Miner Res 25:2460-2469.
18. Hotamisligil GS., 2006. Inflammation and metabolic disorders. Nature 444:860-867.
19. Hsu SM, Raine L, Fanger H. 1981. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580.
20. Ionova-Martin SS, Wade JM, Tang S, Shahnazari M, Ager JW III, Lane NE, Yao W, Alliston T, Vaisse C, Ritchie RO. 2011. Changes in cortical bone response to high-fat diet from adolescence to adulthood in mice. Osteoporos Int 22:2283-2293.
21. Kim BJ, Bae SJ, Lee SY, Lee YS, Baek JE, Park SY, Lee SH, Koh JM, Kim GS. 2012. TNF-alpha mediates the stimulation of sclerostin expression in an estrogen-deficient condition. Biochem Biophys Res Commun 424:170-175.
22. Kimball SR, Horetsky RL, Jefferson LS. 1998. Signal transduction pathways involved in the regulation of protein synthesis by insulin in L6 myoblasts. Am J Physiol 274:C221-C228.
23. Lac G, Cavalie H, Ebal E, Michaux O. 2008. Effects of a high fat diet on bone of growing rats. Correlations between visceral fat, adiponectin and bone mass density. Lipids Health Dis 7:16.
24. Lee HL, Yi T, Woo KM, Ryoo HM, Kim GS, Baek JH. 2010. Msx2 mediates the inhibitory action of TNF-alpha on osteoblast differentiation. Exp Mol Med 42:437-445.
25. Li X, Ominsky MS, Niu QT, Sun N, Daugherty B, D'Agostin D, Kurahara C, Gao Y, Cao J, Gong J, Asuncion F, Barrero M, Warmington K, Dwyer D, Stolina M, Morony S, Sarosi I, Kostenuik PJ, Lacey DL, Simonet WS, Ke HZ, Paszty C. 2008. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 23:860-869.
26. McMahon MS, Ueki Y., 2008. Does anti-TNF-alpha have a role in the treatment of osteoporosis? Bull NYU Hosp Jt Dis 66:280-281.
27. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. 1987. Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610.
28. Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, Demer LL. 2001. Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res 16:182-188.
29. Prod'homme M, Balage M, Debras E, Farges MC, Kimball S, Jefferson L, Grizard J. 2005. Differential effects of insulin and dietary amino acids on muscle protein synthesis in adult and old rats. J Physiol 563:235-248.
30. Reeves PG, Nielsen FH, Fahey GC, Jr. 1993a. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939-1951.
31. Reeves PG, Rossow KL, Lindlauf J. 1993b. Development and testing of the AIN-93 purified diets for rodents: Results on growth, kidney calcification and bone mineralization in rats and mice. J Nutr 123:1923-1931.
32. Roux C. 2011. Anti-TNFα therapy and prevention of bone loss in rheumatoid arthritis. IBMS BoneKEy 8:154-158.
33. Saidenberg-Kermanac'h N, Corrado A, Lemeiter D, deVernejoul MC, Boissier MC, Cohen-Solal ME. 2004. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. Bone 35:1200-1207.
34. Sitnick M, Bodine SC, Rutledge JC. 2009. Chronic high fat feeding attenuates load-induced hypertrophy in mice. J Physiol 587:5753-5765.
35. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G. 2002. Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305-317.
36. Urano T, Shiraki M, Ouchi Y, Inoue S. 2012. Association of circulating sclerostin levels with fat mass and metabolic disease-related markers in Japanese postmenopausal women. J Clin Endocrinol Metab 97:E1473-E1477.
37. Vincent C, Findlay DM, Welldon KJ, Wijenayaka AR, Zheng TS, Haynes DR, Fazzalari NL, Evdokiou A, Atkins GJ. 2009. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. J Bone Miner Res 24:1434-1449.
38. Xiao Y, Cui J, Shi YH, Sun J, Wang ZP, Le GW. 2010. Effects of duodenal redox status on calcium absorption and related genes expression in high-fat diet-fed mice. Nutrition 26:1188-1194.
39. Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y. 2001. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem 276:563-568.
40. Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR, Deng HW. 2007. Relationship of obesity with osteoporosis. J Clin Endocrinol Metab 92:1640-1646.
41. Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, Deng HW. 2008. Correlation of obesity and osteoporosis: Effect of fat mass on the determination of osteoporosis. J Bone Miner Res 23:17-29.